J. P. Devogelaer

2.3k total citations
41 papers, 1.2k citations indexed

About

J. P. Devogelaer is a scholar working on Orthopedics and Sports Medicine, Oncology and Molecular Biology. According to data from OpenAlex, J. P. Devogelaer has authored 41 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Orthopedics and Sports Medicine, 13 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in J. P. Devogelaer's work include Bone health and osteoporosis research (17 papers), Bone health and treatments (12 papers) and Bone and Joint Diseases (7 papers). J. P. Devogelaer is often cited by papers focused on Bone health and osteoporosis research (17 papers), Bone health and treatments (12 papers) and Bone and Joint Diseases (7 papers). J. P. Devogelaer collaborates with scholars based in Belgium, France and United Kingdom. J. P. Devogelaer's co-authors include C Nagant de Deuxchaisnes, Xavier Banse, Jacques Malghem, Serge de Cooman, Marc D. Grynpas, B. Maldague, J.-Y. Reginster, Thierry Duprez, M A Labaisse and Grégoire Dooms and has published in prestigious journals such as Radiology, Bone and Osteoporosis International.

In The Last Decade

J. P. Devogelaer

39 papers receiving 1.2k citations

Peers

J. P. Devogelaer

OSM

ONCOL

RHEUM

SURGE

Y. Boutsen Belgium

J. Dequeker Belgium

J.E. Aaron United Kingdom

M. Varenna Italy

Silvano Adami Italy

W. C. Sturtridge Canada

Giuseppe Martini Italy

D. J. Hosking United Kingdom

Shoichi Ichimura Japan

S. Boonen Belgium

Y. Boutsen Belgium

J. P. Devogelaer

698 ×1.3

OSM

485 ×1.1

ONCOL

329 ×1.0

142 ×0.5

RHEUM

201 ×0.8

SURGE

Citations per year, relative to J. P. Devogelaer J. P. Devogelaer (= 1×) peers Y. Boutsen

Countries citing papers authored by J. P. Devogelaer

Since Specialization

Citations

This map shows the geographic impact of J. P. Devogelaer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. P. Devogelaer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. P. Devogelaer more than expected).

Fields of papers citing papers by J. P. Devogelaer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. P. Devogelaer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. P. Devogelaer. The network helps show where J. P. Devogelaer may publish in the future.

Co-authorship network of co-authors of J. P. Devogelaer

This figure shows the co-authorship network connecting the top 25 collaborators of J. P. Devogelaer. A scholar is included among the top collaborators of J. P. Devogelaer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. P. Devogelaer. J. P. Devogelaer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cavalier, Étienne, Pierre Bergmann, Olivier Bruyère, et al.. (2016). The role of biochemical of bone turnover markers in osteoporosis and metabolic bone disease: a consensus paper of the Belgian Bone Club. Osteoporosis International. 27(7). 2181–2195. 39 indexed citations

Roux, Christian, David M. Reid, J. P. Devogelaer, et al.. (2011). Post hoc analysis of a single IV infusion of zoledronic acid versus daily oral risedronate on lumbar spine bone mineral density in different subgroups with glucocorticoid-induced osteoporosis. Osteoporosis International. 23(3). 1083–1090. 23 indexed citations

Bergmann, P., J.J. Body, Steven Boonen, et al.. (2008). Evidence-based guidelines for the use of biochemical markers of bone turnover in the selection and monitoring of bisphosphonate treatment in osteoporosis: a consensus document of the Belgian Bone Club. International Journal of Clinical Practice. 63(1). 19–26. 114 indexed citations

Omelon, Sidney, Leslie Wise, Eric T. Everett, et al.. (2008). Fluoride effects on bone formation and mineralization are influenced by genetics. Bone. 43(6). 1067–1074. 79 indexed citations

Hul, Els Van, Erik Fransén, J. P. Devogelaer, et al.. (2004). Evaluation of the Role of the SQSTM1 Gene in Sporadic Belgian Patients with Paget’s Disease. Calcified Tissue International. 75(2). 144–152. 43 indexed citations

Banse, Xavier, et al.. (2002). Cross-link profile of bone collagen correlates with structural organization of trabeculae. Bone. 31(1). 70–76. 50 indexed citations

Banse, Xavier & J. P. Devogelaer. (2002). Does Peripheral Quantitative Computed Tomography Ignore Tissue Density of Cancellous Bone?. Journal of Clinical Densitometry. 5(4). 403–410. 5 indexed citations

Banse, Xavier, J. P. Devogelaer, & Marc D. Grynpas. (2002). Patient-specific microarchitecture of vertebral cancellous bone: a peripheral quantitative computed tomographic and histological study. Bone. 30(6). 829–835. 21 indexed citations

Devogelaer, J. P.. (2001). Incidentaloma, glucocorticoid excess and low bone mineral density: a coincidence?. European Journal of Endocrinology. 145(3). 237–239. 6 indexed citations

10.

Eastell, Richard, J. P. Devogelaer, Nicola Peel, et al.. (2000). Prevention of Bone Loss with Risedronate in Glucocorticoid-Treated Rheumatoid Arthritis Patients. Osteoporosis International. 11(4). 331–337. 104 indexed citations

11.

Pesch, Vincent Van, Michel Jadoul, Christine Lefebvre, et al.. (1999). Clinical Significance of Antiproteinase 3 Antibody Positivity in cANCA-Positive Patients. Clinical Rheumatology. 18(4). 279–282. 10 indexed citations

12.

Kaufman, JM, Juliet Compston, M Audran, et al.. (1999). Recommendations for the Registration of Drugs Intended for Use in the Treatment of Male Osteoporosis. Calcified Tissue International. 65(1). 4–7. 5 indexed citations

13.

Devogelaer, J. P., et al.. (1998). Long-term effects of percutaneous estradiol on bone loss and bone metabolism in postmenopausal hysterectomized women. Maturitas. 28(3). 243–249. 18 indexed citations

14.

Stevenson, J. Court, U Gaspard, Bernard Avouac, et al.. (1998). Points to consider for the development of new indications for hormone replacement therapies and estrogen-like molecules. Climacteric. 1(1). 12–17. 4 indexed citations

15.

Lambert, Michel, Catherine Hubert, G Depresseux, et al.. (1997). Hematological changes in anorexia nervosa are correlated with total body fat mass depletion. International Journal of Eating Disorders. 21(4). 329–334. 48 indexed citations

16.

Roux, Christian, C. Gennari, Jordi Farrerons, et al.. (1995). Comparative prospective, double‐blind, multicenter study of the efficacy of tiludronate and etidronate in the treatment of paget's disease of bone. Arthritis & Rheumatism. 38(6). 851–858. 98 indexed citations

17.

Devogelaer, J. P. & C Nagant de Deuxchaisnes. (1995). Fluoride therapy of type I osteoporosis. Clinical Rheumatology. 14(S3). 26–31. 13 indexed citations

18.

Lachapelle, Jean‐Marie, et al.. (1986). Cutaneous mucinosis associated with multiple frozen joints and bony heterotopic deposits around the hips. Clinical Rheumatology. 5(2). 245–251.

19.

Devogelaer, J. P., et al.. (1984). Pseudohypoparathyroidism a Case Report, With Studies on the Pathogenesis of the Condition. Acta Clinica Belgica. 39(4). 228–247. 1 indexed citations

20.

Maldague, B, et al.. (1980). The action of the main therapeutic regimes on paget's disease of bone, with a note on the effect of vitamin d deficiency. Arthritis & Rheumatism. 23(10). 1215–1234. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact